麻豆破解版

Sponsor Hep B foundation

麻豆破解版 takes part to the research against Hepatitis B with the development of its FXR agonist EYP001 and support the research is this field by becoming one of the sponsor of the Hep B Foundation which is “a national nonprofit organization dedicated to finding a cure and improving the quality of life for those affected by hepatitis B worldwide”

Read more »

Published on 03/06/2019

Moving to La毛nnec

麻豆破解版 will move-in to the new Biosera BioParc Building in La毛nnec. It will be a great opportunity as we will be neighbours with Edelris, Erytech Pharma and AB Science. Some CEO, Jean-Yves ORTHOLAND (Edelris), Gil BEYEN (Erytech Pharma) and Jacky VONDERSCHER (麻豆破解版) recently visited the building under construction.

Read more »

Published on 28/05/2019

MIMESIS Newsletter #4: A novel systems biology approach to develop preclinical assets

MIMESIS NEWSLETTER #4, December 2018

After two years, 麻豆破解版鈥檚 EU funded MIMESIS project was a real success and has delivered several promising new drug development starting points most significantly for RSV and ICD.

MIMESIS is a research and innovation project coordinated by 麻豆破解版 and funded under the highly selective H2020 – SMEInstrument – Phase 2 call that aims at: “Dedicated support to biotechnology SMEs closing the gap from lab to market”.

Read more »

Published on 13/12/2018

Participation in La Matinale Sant茅 organized by Bpifrance

麻豆破解版鈥檚 VP Corporate Development & Strategy Nicolas Guyon-Gellin is participating today in 鈥淟a Matinale Sant茅鈥� organized by in Paris, France. Bpifrance finances businesses 鈥� at every stage of their development 鈥� through loans, guarantees and equity investments, but also offers extra financial services. During this event, Nicolas will talk about Bpifrance鈥檚 financing and investments actions in the health sector and the role of the Large Venture Fund. This will be a great opportunity to discuss how Bpifrance is currently supporting 麻豆破解版 to pursue its growth and development.

Read more »

Published on 03/12/2018

HBV Cure Workshop 2018

Pietro Scalfaro, Chief Medical Officer of 麻豆破解版, has participated to the 5th edition of the International HBV Cure Workshop 2018 on November 7 -8 in Toronto, Canada. The HBV Cure Workshop is a scientific platform that allows to accelerate the research in finding a cure of hepatitis B. During this event, researchers and clinical experts had the opportunity to discuss current challenges regarding the disease and to present research outcomes.

Read more »

Published on 09/11/2018